Approval · Notice of Compliance 22371 · 2019
OPTICROM: Notice of Compliance 22371
Issued July 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22371
- Date
- July 5, 2019
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates to comply with the plain language labelling regulations. product monograph transition to the latest template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTICROM | Not yet assigned | — |
Medicinal ingredients
- CROMOLYN SODIUM 0.2 MG per ML